Abstract:SESSION TITLE: Cough SESSION TYPE: Original Investigation Slide PRESENTED ON: Sunday, April 17, 2016 at 08:30 AM - 09:30 AM PURPOSE: There is no systematic review of randomized controlled trials of the regulation function of GABAB receptor agonists for human cough. The study objectives was to evaluated GABAB receptor agonists on regulating human cough. METHODS: Claims data from the MEDLINE, EMBASE, LILACS, CBM, CNKI, VIP, WanFang and the Cochrane Library databases were used to conduct retrospective cohort analyses. We review articles and reference lists of relevant articles prior to 4 September 2015 (Table 1) for human with restrictions as to language of English or Chinese. Two authors independently reviewed the titles and abstracts of the retrieved studies of GABA-agonist (baclofen or arbaclofen) which were matched using Review Manager 5.3 software. Then we extracted relevant data by outcome for therapy group of GABAB receptor agonists and for the control group of placebo or medicine. The outcome data were number of subjects whose cough threshold to inhaled capsaicin C5 increased after treatment or those symptom decline. Disagreements were resolved by consensus. RESULTS: Seven RCTs including 256 persons in total were enrolled in this study and all associated with baclofen, in which 61% of participants were patients and 39% were healthy adult volunteers (Table 2 and 3). After treatment the elevated effect on C5 or relief of cough symptoms was significant (OR13.50 (95%CI: (1.43-127.17), P =0.03) in subgroup of baclofen versus placebo. and the outcome has no statistics differences (OR1.31 (95%CI: (0.64-2.68), P =0.47) in subgroup of baclofen versus medicine (Figure 1). Baclofen was well tolerated with minimal side effects, which were specifically mentioned in two studies. Methodological biases in the design and execution of cluster randomised trials might contributed to the selection bias in this review (Figure 2.1 and 2.2). CONCLUSIONS: We confirm the recent observation that therapy with GABAB receptor agonists (baclofen) diminishes cough reflex sensitivity in asymptomatic human subjects and increase the antitussive activity for patients of cough. Different methodological might contributed to a selection bias in our results. CLINICAL IMPLICATIONS: For patients chronically maintained on oral baclofen for the treatment muscle spasm therapy diminishes cough reflex sensitivity. Due attention should be paid to these asymptomatic of cough for avoiding aspiration. While for patients of cough GABAB receptor agonists such as baclofen increase the antitussive activity and may represent novel therapeutic approaches for a cough hypersensitivity syndrome. DISCLOSURE: The following authors have nothing to disclose: Weili Wei, Yangzi ZhangTong, Qiang Chen, Li Yu, Zhongmin Qiu No Product/Research Disclosure Information

A Systematic Review and Meta-analysis of Randomized, Double-Blind, Placebo-Controlled Trials of GABAB Receptor Agonists on Regulating Human Cough

Randomized double-blind placebo-controlled trial evaluating pregabalin for chronic cough in patients with lung cancer.

Systematic literature review of treatments used for refractory or unexplained chronic cough in adults

Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trial

Cough: some aspects of pathogenesis and therapeutic approaches

Are School Feeding Programs in Low-Income Settings Sustainable? Insights on the Costs of School Feeding Compared with Investments in Primary Education

Bronchodilator therapy for chronic cough

New Strategy for Cough Treatment-Comparison Effect and Safety of Cofetol Cough Syrup with Dextromethorphan Hydrobromide, Chorpheniramine Mateate and Pseudoe Phedrine Hydiochloride Solution in the Treatment of Acute Cough

Comparison of ultrasound‐guided core‐needle biopsy and fine‐needle aspiration in the assessment of head and neck lesions

Central pathways for cough in man--unanswered questions

Effects of a novel GABA‐B positive allosteric modulator, ASP8062, on alcohol cue‐elicited craving and naturalistic alcohol consumption in a multisite randomized, double‐blind, placebo‐controlled trial

GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteers

From bench to bedside: The role of cough hypersensitivity in chronic cough

Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough

Depression of cough reflex by microinjections of antitussive agents into caudal ventral respiratory group of the rabbit

Translating Cough Mechanisms Into Better Cough Suppressants

Future Directions in Chronic Cough

ERS guidelines on the diagnosis and treatment of chronic cough in adults and children

Systematic review and meta-analysis: proton pump inhibitors slightly decrease the severity of chronic cough

A randomized, double-blinded, placebo-controlled clinical trial of duloxetine hydrochloride enteric-coated tablets in the treatment of refractory chronic cough

Anatomy and neurophysiology of cough: CHEST Guideline and Expert Panel report